Wacker Chemie Yönetim
Yönetim kriter kontrolleri 3/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Christian Hartel
İcra Kurulu Başkanı
€2.0m
Toplam tazminat
| CEO maaş yüzdesi | 43.17% |
| CEO görev süresi | 10.5yrs |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 10.5yrs |
| Yönetim Kurulu ortalama görev süresi | 10.2yrs |
Son yönetim güncellemeleri
Recent updates
Anlatı Güncellemesi • May 02
WCH: Future Returns Will Depend On Delivering Cautious 2026 Earnings Guidance
Analysts have lifted their fair value estimate for Wacker Chemie from €73.50 to about €81.43, citing updated assumptions on revenue growth, profitability and future P/E multiples following several recent upgrades and price target increases from major research houses. Analyst Commentary Bullish Takeaways Bullish analysts point to a series of recent upgrades as support for a higher fair value range, linking their stance to refreshed assumptions on revenue, margins and the P/E multiple they are willing to apply.
Anlatı Güncellemesi • Apr 17
WCH: Supportive Research Tone Will Sustain Richer Future P/E Expectations
Analysts have nudged the fair value estimate for Wacker Chemie up to €96.00 from about €95.45, citing a higher assumed revenue growth rate, a revised future P/E of roughly 20.7, and a series of recent price target increases and upgrades from major banks. Analyst Commentary Recent Street research has tilted more supportive, with several bullish analysts revising their views in a way that reinforces the higher fair value estimate and the assumed future P/E of about 20.7. Some have raised price targets, including one increase to €61 from €59 alongside an Underweight rating, while others have moved to more positive stances through upgrades and more constructive commentary.Anlatı Güncellemesi • Apr 02
WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance
Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.
Anlatı Güncellemesi • Mar 18
WCH: Higher P/E Assumptions Will Likely Fail To Support Rich Share Price
Analysts have lifted their price target on Wacker Chemie to €61 from €59, reflecting updated views on revenue growth, profit margins and future P/E assumptions, while keeping the fair value estimate unchanged. Analyst Commentary Recent research on Wacker Chemie points to a mixed backdrop, with some price target adjustments reflecting caution around execution risks, earnings visibility and how the shares are valued against these factors.Anlatı Güncellemesi • Mar 04
WCH: Margin Execution Risks Will Likely Cap Share Upside Despite Upgrades
Analysts have raised their price target on Wacker Chemie to €50, citing firmer margin expectations and a lower assumed future P/E, supported by recent upgrades from major houses. Analyst Commentary Recent research reports on Wacker Chemie point to a more constructive view on margins and valuation, but you still see a strand of caution in the background.Anlatı Güncellemesi • Feb 18
WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple
Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.Anlatı Güncellemesi • Feb 03
WCH: Fair Outlook Will Depend On Restructuring Progress And Section 232 Resolution
Analysts have nudged their fair value estimate for Wacker Chemie higher to €69.57 from €67.36, reflecting updated views on margins and P/E assumptions, alongside mixed rating actions from recent Street research. Analyst Commentary Recent Street research shows a split view on Wacker Chemie, with some analysts turning more positive while others take a more cautious stance around execution and policy risks.Anlatı Güncellemesi • Jan 20
WCH: Section 232 Uncertainty Will Likely Cap Near Term Share Upside
Analysts have adjusted their average price target for Wacker Chemie to €73, reflecting a more cautious stance that aligns with recent Neutral and Equal Weight views as they wait for clarity on Section 232 outcomes and the company’s restructuring plans. Analyst Commentary Recent commentary around Wacker Chemie has taken a more cautious tone, with coverage starting at a neutral stance and an existing recommendation cut back to Neutral alongside a €73 price target.Anlatı Güncellemesi • Jan 06
WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome
Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.Analiz Makalesi • Jan 05
Revenues Tell The Story For Wacker Chemie AG (ETR:WCH)
With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...Anlatı Güncellemesi • Dec 18
WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares
Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.Anlatı Güncellemesi • Dec 04
WCH: Future Performance Will Depend On Restructuring Progress And Section 232 Decisions
Analysts have trimmed their fair value estimate for Wacker Chemie by roughly EUR 1 to about EUR 67. This reflects slightly softer growth expectations and more cautious price targets following a wave of Neutral and Hold ratings.Anlatı Güncellemesi • Nov 20
WCH: Near-Term Performance Will Depend On Restructuring Progress And Policy Outcomes
Wacker Chemie's analyst price target has seen a modest decrease to €68.29 from €69, as analysts cite cautious outlooks regarding restructuring progress and ongoing external uncertainties. Analyst Commentary Recent analyst activity on Wacker Chemie has provided a spectrum of perspectives on the company’s outlook, as reflected in their updated ratings and price targets.Anlatı Güncellemesi • Nov 05
WCH: Future Earnings Will Face Margin Pressure As Cautious Outlook Persists
Wacker Chemie’s fair value estimate has been raised from €66.33 to €69.00. This change reflects analysts’ updated outlook based on adjusted forecasts for discount rates, future revenue growth, and profit margins.Analiz Makalesi • Oct 26
What Is Wacker Chemie AG's (ETR:WCH) Share Price Doing?
Wacker Chemie AG ( ETR:WCH ), might not be a large cap stock, but it saw a decent share price growth of 13% on the XTRA...Anlatı Güncellemesi • Oct 22
Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts
Wacker Chemie's analyst price target has been revised downward from €68.92 to €66.33, with analysts citing slightly reduced expectations for revenue growth and profit margins as reasons for the change. Analyst Commentary Recent price target revisions for Wacker Chemie signal mixed sentiment in the market, as analysts evaluate the company’s prospects in light of changing expectations for revenue and profitability.Anlatı Güncellemesi • Oct 08
Polysilicon And Renewable Energy Investments Will Drive Future Value
Wacker Chemie's analyst price target has been revised downward, decreasing by approximately EUR 2.72 to EUR 68.92. Analysts note expectations for softer revenue growth and profit margins in their latest forecasts.Analiz Makalesi • Sep 29
Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Anlatı Güncellemesi • Sep 19
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have lowered Wacker Chemie’s price target to €71.64, citing ongoing margin pressures, weak end-market demand, and reduced earnings visibility, driving a more cautious sector outlook. Analyst Commentary Bearish analysts cite continued margin pressures in key business segments, weighing on profit forecasts.Anlatı Güncellemesi • Sep 04
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have become more cautious on Wacker Chemie due to rising short-term earnings risks and macroeconomic uncertainty, resulting in price target downgrades and more conservative recommendations, with the consensus analyst price target unchanged at €75.79. Analyst Commentary Bearish analysts cite increased short-term risks to Wacker Chemie’s earnings momentum as a key factor behind lowered price targets.Analiz Makalesi • Sep 02
Wacker Chemie AG's (ETR:WCH) Business Is Yet to Catch Up With Its Share Price
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...Analiz Makalesi • Aug 03
Analyst Estimates: Here's What Brokers Think Of Wacker Chemie AG (ETR:WCH) After Its Half-Yearly Report
It's been a mediocre week for Wacker Chemie AG ( ETR:WCH ) shareholders, with the stock dropping 10% to €64.00 in the...Analiz Makalesi • Jun 20
Should You Think About Buying Wacker Chemie AG (ETR:WCH) Now?
While Wacker Chemie AG ( ETR:WCH ) might not have the largest market cap around , it received a lot of attention from a...Analiz Makalesi • May 30
Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Yeni Anlatı • Dec 22
Specialty Silicones And Biosolutions Expansion Will Propel Earnings And Boost Net Margins
Investment in specialty silicones and focus on high-margin specialties forecast improved net margins and earnings through enhanced portfolio management.CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -€803m |
| Dec 31 2025 | n/a | n/a | -€821m |
| Sep 30 2025 | n/a | n/a | €22m |
| Jun 30 2025 | n/a | n/a | €136m |
| Mar 31 2025 | n/a | n/a | €189m |
| Dec 31 2024 | €2m | €880k | €241m |
| Sep 30 2024 | n/a | n/a | €124m |
| Jun 30 2024 | n/a | n/a | €124m |
| Mar 31 2024 | n/a | n/a | €214m |
| Dec 31 2023 | €2m | €772k | €314m |
| Sep 30 2023 | n/a | n/a | €515m |
| Jun 30 2023 | n/a | n/a | €739m |
| Mar 31 2023 | n/a | n/a | €1b |
| Dec 31 2022 | €2m | €750k | €1b |
| Sep 30 2022 | n/a | n/a | €1b |
| Jun 30 2022 | n/a | n/a | €1b |
| Mar 31 2022 | n/a | n/a | €1b |
| Dec 31 2021 | €2m | €688k | €807m |
| Sep 30 2021 | n/a | n/a | €582m |
| Jun 30 2021 | n/a | n/a | €403m |
| Mar 31 2021 | n/a | n/a | €227m |
| Dec 31 2020 | €2m | €580k | €189m |
| Sep 30 2020 | n/a | n/a | -€619m |
| Jun 30 2020 | n/a | n/a | -€599m |
| Mar 31 2020 | n/a | n/a | -€568m |
| Dec 31 2019 | €2m | €580k | -€643m |
Tazminat ve Piyasa: Christian 'ın toplam tazminatı ($USD 2.37M ) German pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.63M ).
Tazminat ve Kazançlar: Christian şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Christian Hartel (54 yo)
10.5yrs
Görev süresi
€2,038,246
Tazminat
Dr. Christian Hartel has been Member of Executive Board at Wacker Chemie AG since November 1, 2015, President and Chief Executive Officer since May 12, 2021 and served as its President of Wacker Silicones...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Member of Executive Board | 10.5yrs | €2.04m | Veri yok | |
| CFO & Member of the Executive Board | 13.3yrs | €1.64m | Veri yok | |
| Head of Human Resource | 10.5yrs | €1.19m | Veri yok | |
| Member of the Executive Board | 3yrs | €1.84m | Veri yok | |
| Head of Corproate Accounting & Tax | no data | Veri yok | Veri yok | |
| Head of Investor Relations | no data | Veri yok | Veri yok | |
| Senior Vice President of Corporate Engineering & CDO Operations | no data | Veri yok | Veri yok | |
| President of Biosolutions division | no data | Veri yok | Veri yok | |
| Senior VP of Corporate R&D and Head of Consortium | no data | Veri yok | Veri yok | |
| President of Polymers Business | 9.6yrs | Veri yok | Veri yok |
10.5yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim: WCH 'un yönetim ekibi deneyimli ve deneyimlidir ( 10.5 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of Supervisory Board | 18yrs | €325.00k | Veri yok | |
| Employee Representative Deputy Chairman of Supervisory Board | 23.1yrs | €225.00k | Veri yok | |
| Member of Supervisory Board | 18yrs | €125.00k | Veri yok | |
| Member of Supervisory Board | 18yrs | €175.00k | Veri yok | |
| Employee Representative Member of the Supervisory Board | 2.6yrs | €125.00k | Veri yok | |
| Independent Member of Supervisory Board | 11.3yrs | €156.37k | Veri yok | |
| Independent Member of Supervisory Board | 13yrs | €125.00k | Veri yok | |
| Employee Representative Member of Supervisory Board | 9.1yrs | €175.00k | Veri yok | |
| Independent Member of Supervisory Board | 8yrs | €125.00k | Veri yok | |
| Employee Representative Member of Supervisory Board | 8yrs | €125.00k | Veri yok | |
| Independent Member of Supervisory Board | 4yrs | €225.00k | Veri yok | |
| Employee Representative Member of Supervisory Board | 3.3yrs | €125.00k | Veri yok |
10.2yrs
Ortalama Görev Süresi
55.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: WCH 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.2 yıldır).
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/21 06:01 |
| Gün Sonu Hisse Fiyatı | 2026/05/21 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Wacker Chemie AG 31 Bu analistlerden 13, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Laura Lopez Pineda | Baader Helvea Equity Research |